Wednesday, March 25, 2015

VBL Therapeutics' brain cancer drug succeeds in mid-stage study

Israel-based VBL Therapeutics said a mid-stage study of its experimental brain cancer drug met the main goal of increasing overall survival.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)